Trademark: 87089769
Word
GALXC
Status Date
Monday, March 29, 2021
Filing Date
Thursday, June 30, 2016
Published for Opposition
Tuesday, December 26, 2017
Abandoned Date
Monday, March 29, 2021
5 Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; Biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; and drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
40 custom manufacture of oligonucleotides
42 research and development of anti-cancer drugs and anti-cancer preparations; research and development of pharmaceutical products
Color is not claimed as a feature of the mark.
The mark consists of a stylized version of the term "GALXC".
Mar 29, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 29, 2021
Abandonment - No Use Statement Filed
Feb 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 25, 2021
Teas Change Of Correspondence Received
Feb 25, 2021
Teas Change Of Owner Address Received
Aug 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2020
Extension 5 Granted
Aug 12, 2020
Extension 5 Filed
Aug 18, 2020
Case Assigned To Intent To Use Paralegal
Aug 12, 2020
Teas Extension Received
Feb 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 13, 2020
Extension 4 Granted
Feb 13, 2020
Extension 4 Filed
Feb 13, 2020
Teas Extension Received
Aug 14, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 12, 2019
Extension 3 Granted
Aug 12, 2019
Extension 3 Filed
Aug 12, 2019
Teas Extension Received
Jun 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 12, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 10, 2019
Extension 2 Granted
Jan 10, 2019
Extension 2 Filed
Jan 10, 2019
Teas Extension Received
Aug 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2018
Extension 1 Granted
Aug 20, 2018
Extension 1 Filed
Aug 20, 2018
Teas Extension Received
Jul 23, 2018
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 20, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Nov 17, 2017
Approved For Pub - Principal Register
Nov 2, 2017
Teas/Email Correspondence Entered
Nov 2, 2017
Correspondence Received In Law Office
Nov 2, 2017
Teas Request For Reconsideration Received
May 3, 2017
Notification Of Final Refusal Emailed
May 3, 2017
Final Refusal E-Mailed
May 3, 2017
Final Refusal Written
Apr 11, 2017
Teas/Email Correspondence Entered
Apr 10, 2017
Correspondence Received In Law Office
Apr 10, 2017
Teas Response To Office Action Received
Oct 11, 2016
Notification Of Non-Final Action E-Mailed
Oct 11, 2016
Non-Final Action E-Mailed
Oct 11, 2016
Non-Final Action Written
Oct 11, 2016
Assigned To Examiner
Jul 15, 2016
Teas Amendment Entered Before Attorney Assigned
Jul 15, 2016
Teas Voluntary Amendment Received
Jul 5, 2016
New Application Office Supplied Data Entered In Tram
Jul 4, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
